DAAC THERAPEUTICS

Welcome to the Brand page for “DAAC THERAPEUTICS”, which is offered here for Pharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medicines, proteins, biomolecules in the nature of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and amino acid metabolites for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medical foods, food that is intended for the specific dietary management of a disease or condition; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; dietary and nutritional supplements;defined amino acid composition;chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in scientific and medical research; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, and nutrients and nutritive products for use in the manufacture of beverages, food products and food supplements for human and non-human use; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, and muscle, bones, joints, and whole body movement; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussion, movement disorders, dystrophies, anemias, and orphan diseases; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for in vitro medical research and in vivo scientific research;therapeutics;.

Its status is currently believed to be active. Its class is unavailable. “DAAC THERAPEUTICS” is believed to be currently owned by “Axcella Health Inc.”